Pincelli Thais P, Zawawi Suha, Shapiro Shane A, Heckman Michael G, Hochwald Alexander P, Arthurs Jennifer, Tolaymat Leila, Bruce Alison
From the Department of Dermatology, Mayo Clinic Florida, Jacksonville, Fla.
Center for Regenerative Biotherapeutics, Mayo Clinic Florida, Jacksonville, Fla.
Plast Reconstr Surg Glob Open. 2024 May 20;12(5):e5829. doi: 10.1097/GOX.0000000000005829. eCollection 2024 May.
The regenerative properties of platelet growth factors make platelet-rich-plasma (PRP) an attractive modality for treatment of aging skin. The main objective of this study was to determine efficacy and safety of PRP injections and microneedling compared with saline injections in women with aging skin of the face.
In this prospective, randomized clinical trial, 18 women with facial aging were randomized to receive either PRP injections to the unilateral face and saline injections to the contralateral side, or vice versa. Microneedling was performed after injections on the entire face. Physician assessment, photographs, and treatment satisfaction questionnaires were used for outcome assessment at baseline and 16- and 24-week follow-ups.
There was no evidence of improvement and suggestion of worsening in skin laxity and rhytides from baseline to weeks 4, 16, and 24 for PRP and saline (all ≤ 0.004) and no notable difference in skin roughness between baseline and follow-up time points for PRP or saline (all ≥ 0.19). The degree of change in skin laxity, rhytides, and skin roughness from baseline to follow-up time points was similar for PRP and saline. All patients experienced some degree of pain/discomfort and burning/stinging sensation at treatment weeks 4, 8, and 12 for both saline and PRP.
PRP injections did not seem to be effective for treatment of aging skin of the face in women, with no notable macroscopic improvement in appearance when compared with baseline or saline injections. Advanced age of study participants (>45 years) and less-sensitive methods of evaluation may be potential contributing factors to the lack of detected response.
血小板生长因子的再生特性使富含血小板血浆(PRP)成为治疗皮肤老化的一种有吸引力的方式。本研究的主要目的是确定与生理盐水注射相比,PRP注射和微针治疗对面部皮肤老化女性的疗效和安全性。
在这项前瞻性随机临床试验中,18名面部老化女性被随机分为两组,一组接受单侧面部PRP注射,对侧接受生理盐水注射,另一组反之。注射后对全脸进行微针治疗。在基线、16周和24周随访时,通过医生评估、照片和治疗满意度问卷进行结果评估。
从基线到第4、16和24周,PRP组和生理盐水组在皮肤松弛和皱纹方面均无改善迹象,且有恶化趋势(均≤0.004),PRP组和生理盐水组在基线和随访时间点之间的皮肤粗糙度无显著差异(均≥0.19)。PRP组和生理盐水组从基线到随访时间点的皮肤松弛、皱纹和皮肤粗糙度变化程度相似。生理盐水组和PRP组的所有患者在治疗第4、8和12周时均经历了一定程度的疼痛/不适以及灼烧/刺痛感。
PRP注射似乎对面部皮肤老化女性无效,与基线或生理盐水注射相比,外观上没有明显的宏观改善。研究参与者年龄较大(>45岁)以及评估方法不够敏感可能是未检测到反应的潜在因素。